DWB at ASC is performed for the early detection of malignant tumours.
According to the most recent data in the scientific literature, DWB has a sensitivity of approximately 90% for the detection of malignant tumours (primary or metastatic), i.e. it is able to identify 90 out of 100 malignant tumour lesions; this means that 1 in 10 tumours are not detected.
This percentage is very high, comparable to that of a PET scan: compared to this, DWB has the advantage of being completely harmless, because it does not expose the patient to radiation, nor is the injection of contrast necessary.
